up home page bottom

French German version Spanish version Italian version

header image

ETHEX Corporation Issues Voluntary Nationwide Recall Of Prescription Prenatal and Iron Supplements

If you are currently taking prescription prenatal and iron supplements, check with your health your health provider. FOR IMMEDIATE RELEASE — St. Louis, MO, February 3, 2009 – ETHEX Corporation, a subsidiary of KV Pharmaceutical Company (NYSE: KVa/KVb), is issuing a voluntary nationwide recall of the products identified below (all lots within their expiration dates) [...]

Share

FDA — Progress in Protecting the Food Supply

The following is a FDA Press Release concerning the safety of the nations food supply. It will either cheer you, or chill you. Bottom line— buy locally and in-season foods and a lot of the worry goes away. FOR IMMEDIATE RELEASE December 1, 2008 Media Inquiries: Stephanie Kwisnek, 301-827-0955 Consumer Inquiries: 888-INFO-FDA FDA Reports Significant [...]

Share

Urgent Voluntary Nationwide Recall Of Infants’ Mylicon Gas Relief Dye Free Drops

Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Johnson and Johnson–Merck Consumer Pharmaceuticals Company Announces Urgent Voluntary Nationwide Recall Of Infants’ [...]

Share

FDA Addresses Questions About Gardasil®

Those of you who are regular readers know that I think Gardasil® is the wrong solution for preventing Cervical Cancer. It is my considered opinion that Gardasil® has one purpose — it is a much needed cash cow for Merck, in their time of financial need.  My attempt at “Fair and Balanced” reporting is to [...]

Share

Science Experiment Likely To End Up on Your Dinner Table

FDA Releases Draft Guidance on Regulation of Genetically Engineered Animals Printer-friendly PDF (420 KB) On this page: Genetic Engineering Benefits of GE Animals GE Animals Regulated Under New Animal Drug Provisions The Food and Drug Administration (FDA) is inviting the public to comment on draft guidance that discusses FDA’s approach to regulating genetically engineered (GE) [...]

Share

Merck Wins Expanded Uses for Gardasil®

FDA News FOR IMMEDIATE RELEASE September 12, 2008 Media Inquiries: Karen Riley, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves Expanded Uses for Gardasil® to Include Preventing Certain Vulvar and Vaginal Cancers The U.S. Food and Drug Administration today announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human [...]

Share

New Safety Information Identified by the Adverse Event Reporting System (AERS)

Potential Signals of Serious Risks What is FDA posting? The following reports list any potential signals of serious risks/new safety information that were identified using the AERS database during the indicated quarter. The appearance of a drug on this list does not mean that FDA has concluded that the drug has this listed risk. It [...]

Share

FDA Unveils List of 20 Drugs In Side-Effect Probes

Goal Is to Provide Signs of Possibility Of Adverse Effects By JARED A. FAVOLE WSJ.com, September 5, 2008 8:07 p.m. WASHINGTON — The Food and Drug Administration on Friday unveiled a report listing 20 drugs that the agency is investigating for potential side effects, as part of a new policy to warn patients and health-care [...]

Share

Using biological medicines used during pregnancy and breast-feeding…

FDA News FOR IMMEDIATE RELEASE May 28, 2008 Media Inquiries: Susan Cruzan, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Proposes New Rule to Provide Updated Information on the Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding The U.S. Food and Drug Administration today proposed major revisions to the physician labeling for prescription drugs (including [...]

Share

New Genetic Test for Patients with Breast Cancer

FOR IMMEDIATE RELEASE July 8, 2008 Media Inquiries: Karen Riley, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Genetic Test for Patients with Breast Cancer The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab). The SPOT-Light [...]

Share